News

Owens & Minor Names Chief Operating Officer

Owens & Minor, a global healthcare solutions company providing essential products, services and technology solutions that support care delivery in leading hospitals, health systems and research centers around the world, today announced Marc Rottink as Chief Operating Officer (COO) of Owens & Minor, effective immediately.

Rottink brings almost three decades of experience in leading global, multi-site healthcare supply chain operations, including strategic transformation, oversight and management of global inventory assets and distribution operations, integrated business planning, systems implementation, and cross-functional operations alignment. Most recently, Marc served as Senior Vice President of Global Supply Chain and Customer Care for Smith + Nephew. Under his leadership, Smith + Nephew saw significant improvement in its manufacturing operations, as well as sales, inventory, and operational planning (SIOP), greatly enhancing customer fulfillment levels. Prior to Smith + Nephew, Marc served as Vice President of Global Supply Chain for Medtronic’s Restorative Therapies Group.

“In logistics, operational excellence is important, but in healthcare logistics, it’s critical,” said Christian Cook, chairman and interim CEO, Owens & Minor, and managing director at Platinum Equity. “We’re making significant investments in our operations through automation and we’re confident that Marc’s impressive history of successfully leading global operational transformation will be a pivotal asset as Owens & Minor continues to improve the customer experience.”

“Throughout my career, I’ve had great passion for developing and implementing large-scale strategies that help supply chains and product manufacturing operate more efficiently and more responsively,” said Marc Rottink, Chief Operating Officer (COO), Owens & Minor. “I’m more than thrilled to join Owens & Minor and excited for the opportunity to innovate and improve the backbone of our strength—our 140+ years of operational expertise—and take it to the next level.”

On December 31, 2025, Owens & Minor announced a new chapter in its long and storied history: the medical distribution, products and technology services business, formerly referred to as Products & Healthcare Services (P&HS), is now part of the Platinum Equity portfolio. The company continues to operate as a private standalone company under the Owens & Minor name, carrying on the legacy of excellence and service the company has long been known for.

Read more here.

Recent News

09/17/2026

Rivanna Announces New CMS Procedure Code for Computer-aided Neuraxial Guidance

RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the Centers for Medicare & Medicaid Services (CMS) has established ICD-10-PCS code XEZU3HC, effective for inpatient discharges beginning October 1, 2026. The code identifies computer-aided intraprocedural navigation in the spinal canal using ultrasound imaging with continuous needle tracking via a percutaneous approach during neuraxial anesthesia. …

09/17/2026

From Lab to Three Continents: Agrospheres and FMC Corporation Advance Bioinsecticide Pipeline into Global Field Trials

AgroSpheres, a biotechnology company pioneering breakthroughs in sustainable crop protection and FMC Corporation (NYSE: FMC), a global leader in agricultural sciences, today announced a significant advancement in its ongoing collaboration. Two proprietary RNA-based biomolecule candidates from AgroSpheres’ pipeline are now entering global field trial development, marking the transition from discovery into real-world testing across three …

09/15/2026

Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (“Jazz” or the “Company”) today announced the successful completion of its acquisition of privately-held Actio Biosciences, Inc. (“Actio”) for $820 million upfront. Actio is now a wholly-owned subsidiary of Jazz. “ABS-1230 holds the promise of being a transformative, first-in-class therapy for individuals living with KCNT1-related epilepsy,” said Renee Gala, president and …